Cargando…

Heart Failure Duration Combined with Left Atrial Dimension Predicts Super-Response and Long-Term Prognosis in Patients with Cardiac Resynchronization Therapy Implantation

BACKGROUND: Response to cardiac resynchronization therapy (CRT) varies significantly among patients. This study aimed to identify baseline characteristics that could predict super-response to CRT and to evaluate the long-term prognosis in super-responders. METHODS: We retrospectively reviewed the da...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zhinian, Liu, Xiaoyan, Liu, Chuan, Yang, Jie, Cheng, Xiaofeng, Chen, Yunlong, Li, Ping, He, Yongming, Wang, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613035/
https://www.ncbi.nlm.nih.gov/pubmed/31341894
http://dx.doi.org/10.1155/2019/2983752
_version_ 1783432986851540992
author Guo, Zhinian
Liu, Xiaoyan
Liu, Chuan
Yang, Jie
Cheng, Xiaofeng
Chen, Yunlong
Li, Ping
He, Yongming
Wang, Jiang
author_facet Guo, Zhinian
Liu, Xiaoyan
Liu, Chuan
Yang, Jie
Cheng, Xiaofeng
Chen, Yunlong
Li, Ping
He, Yongming
Wang, Jiang
author_sort Guo, Zhinian
collection PubMed
description BACKGROUND: Response to cardiac resynchronization therapy (CRT) varies significantly among patients. This study aimed to identify baseline characteristics that could predict super-response to CRT and to evaluate the long-term prognosis in super-responders. METHODS: We retrospectively reviewed the data of 73 consecutive patients who received CRT. Patients were considered as super-responders after 6-month follow-up when NYHA class reduction to I or II combined with left ventricular ejection fraction (LVEF) ≥ 50% was observed. Patients were divided into super-responders group and non-super-responders group. All-cause mortality or hospitalization for heart failure (HF) was referred to the combined end point. RESULTS: 17 (23.3%) patients were super-responders. HF duration, left atrial dimension (LAD), and left bundle branch block (LBBB) were independent predictors of super-response to CRT. The combination of HF duration and LAD could provide more robust prediction of super-response than standalone HF duration (0.899 versus 0.789, Z = 2.207, P = 0.027) or standalone LAD (0.899 versus 0.775, Z = 2.487, P = 0.013). super-responders had excellent LV reverse remodeling. The cumulative incidences of combined end point were significantly lower in the super-responders group, LAD ≤ 42mm group, and combination of HF duration ≤ 48 months and LAD ≤ 42mm group. LBBB remained associated with a lowered risk of the combined end point (HR: 0.19, 95% CI: 0.07-0.57, P = 0.003), whereas LAD was associated with a raised risk of the combined end point (HR: 1.09, 95% CI: 1.02-1.17, P = 0.014). CONCLUSIONS: HF duration, LAD, and LBBB independently predicted super-response. The combination of HF duration and LAD makes more robust prediction of CRT super-response. Super-responders had excellent LV reverse remodeling and decreased the incidences of the combined end point. LBBB and LAD were independently associated with the combined end point.
format Online
Article
Text
id pubmed-6613035
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-66130352019-07-24 Heart Failure Duration Combined with Left Atrial Dimension Predicts Super-Response and Long-Term Prognosis in Patients with Cardiac Resynchronization Therapy Implantation Guo, Zhinian Liu, Xiaoyan Liu, Chuan Yang, Jie Cheng, Xiaofeng Chen, Yunlong Li, Ping He, Yongming Wang, Jiang Biomed Res Int Research Article BACKGROUND: Response to cardiac resynchronization therapy (CRT) varies significantly among patients. This study aimed to identify baseline characteristics that could predict super-response to CRT and to evaluate the long-term prognosis in super-responders. METHODS: We retrospectively reviewed the data of 73 consecutive patients who received CRT. Patients were considered as super-responders after 6-month follow-up when NYHA class reduction to I or II combined with left ventricular ejection fraction (LVEF) ≥ 50% was observed. Patients were divided into super-responders group and non-super-responders group. All-cause mortality or hospitalization for heart failure (HF) was referred to the combined end point. RESULTS: 17 (23.3%) patients were super-responders. HF duration, left atrial dimension (LAD), and left bundle branch block (LBBB) were independent predictors of super-response to CRT. The combination of HF duration and LAD could provide more robust prediction of super-response than standalone HF duration (0.899 versus 0.789, Z = 2.207, P = 0.027) or standalone LAD (0.899 versus 0.775, Z = 2.487, P = 0.013). super-responders had excellent LV reverse remodeling. The cumulative incidences of combined end point were significantly lower in the super-responders group, LAD ≤ 42mm group, and combination of HF duration ≤ 48 months and LAD ≤ 42mm group. LBBB remained associated with a lowered risk of the combined end point (HR: 0.19, 95% CI: 0.07-0.57, P = 0.003), whereas LAD was associated with a raised risk of the combined end point (HR: 1.09, 95% CI: 1.02-1.17, P = 0.014). CONCLUSIONS: HF duration, LAD, and LBBB independently predicted super-response. The combination of HF duration and LAD makes more robust prediction of CRT super-response. Super-responders had excellent LV reverse remodeling and decreased the incidences of the combined end point. LBBB and LAD were independently associated with the combined end point. Hindawi 2019-06-24 /pmc/articles/PMC6613035/ /pubmed/31341894 http://dx.doi.org/10.1155/2019/2983752 Text en Copyright © 2019 Zhinian Guo et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Guo, Zhinian
Liu, Xiaoyan
Liu, Chuan
Yang, Jie
Cheng, Xiaofeng
Chen, Yunlong
Li, Ping
He, Yongming
Wang, Jiang
Heart Failure Duration Combined with Left Atrial Dimension Predicts Super-Response and Long-Term Prognosis in Patients with Cardiac Resynchronization Therapy Implantation
title Heart Failure Duration Combined with Left Atrial Dimension Predicts Super-Response and Long-Term Prognosis in Patients with Cardiac Resynchronization Therapy Implantation
title_full Heart Failure Duration Combined with Left Atrial Dimension Predicts Super-Response and Long-Term Prognosis in Patients with Cardiac Resynchronization Therapy Implantation
title_fullStr Heart Failure Duration Combined with Left Atrial Dimension Predicts Super-Response and Long-Term Prognosis in Patients with Cardiac Resynchronization Therapy Implantation
title_full_unstemmed Heart Failure Duration Combined with Left Atrial Dimension Predicts Super-Response and Long-Term Prognosis in Patients with Cardiac Resynchronization Therapy Implantation
title_short Heart Failure Duration Combined with Left Atrial Dimension Predicts Super-Response and Long-Term Prognosis in Patients with Cardiac Resynchronization Therapy Implantation
title_sort heart failure duration combined with left atrial dimension predicts super-response and long-term prognosis in patients with cardiac resynchronization therapy implantation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613035/
https://www.ncbi.nlm.nih.gov/pubmed/31341894
http://dx.doi.org/10.1155/2019/2983752
work_keys_str_mv AT guozhinian heartfailuredurationcombinedwithleftatrialdimensionpredictssuperresponseandlongtermprognosisinpatientswithcardiacresynchronizationtherapyimplantation
AT liuxiaoyan heartfailuredurationcombinedwithleftatrialdimensionpredictssuperresponseandlongtermprognosisinpatientswithcardiacresynchronizationtherapyimplantation
AT liuchuan heartfailuredurationcombinedwithleftatrialdimensionpredictssuperresponseandlongtermprognosisinpatientswithcardiacresynchronizationtherapyimplantation
AT yangjie heartfailuredurationcombinedwithleftatrialdimensionpredictssuperresponseandlongtermprognosisinpatientswithcardiacresynchronizationtherapyimplantation
AT chengxiaofeng heartfailuredurationcombinedwithleftatrialdimensionpredictssuperresponseandlongtermprognosisinpatientswithcardiacresynchronizationtherapyimplantation
AT chenyunlong heartfailuredurationcombinedwithleftatrialdimensionpredictssuperresponseandlongtermprognosisinpatientswithcardiacresynchronizationtherapyimplantation
AT liping heartfailuredurationcombinedwithleftatrialdimensionpredictssuperresponseandlongtermprognosisinpatientswithcardiacresynchronizationtherapyimplantation
AT heyongming heartfailuredurationcombinedwithleftatrialdimensionpredictssuperresponseandlongtermprognosisinpatientswithcardiacresynchronizationtherapyimplantation
AT wangjiang heartfailuredurationcombinedwithleftatrialdimensionpredictssuperresponseandlongtermprognosisinpatientswithcardiacresynchronizationtherapyimplantation